Published in J Invest Dermatol on May 01, 1980
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol (1985) 0.99
Herpes gestationis. New immunologic findings. Arch Dermatol (1974) 0.99
Complement activation in bullous skin diseases. J Invest Dermatol (1975) 0.98
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Complement activation in pemphigus and bullous pemphigoid. J Invest Dermatol (1976) 0.96
Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol (1980) 0.96
Antinuclear antibodies: their significance in scleroderma. Mayo Clin Proc (1971) 0.95
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94
Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol (1989) 0.93
Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol (1988) 0.93
Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol (1985) 0.93
Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol (1977) 0.91
Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol (1996) 0.90
Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. J Invest Dermatol (1986) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
"An unusual type of pemphigus combining features of lupus erythematosus" by Senear and Usher, June 1926. Commentary: Pemphigus erythematosus, a unique member of the pemphigus group. Arch Dermatol (1982) 0.88
Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies. Proc Soc Exp Biol Med (1976) 0.87
Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol (1984) 0.87
Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol (1978) 0.87
Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. J Lab Clin Med (1990) 0.86
Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage. Br J Dermatol (1978) 0.86
The complement system in pemphigus, bullous pemphigoid and herpes gestationis. Int J Dermatol (1979) 0.86
Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus. Br J Dermatol (1975) 0.85
Pemphigus-like antibodies in bullous pemphigoid. Arch Dermatol (1977) 0.85
Neonatal pemphigus foliaceus. Arch Dermatol (1995) 0.82
The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid. Clin Immunol Immunopathol (1976) 0.82
The particulate (speckled-like thread) nuclear staining pattern: species and cellular distribution of Ro/SSA antigen. J Clin Lab Immunol (1987) 0.82
Immunofluorescent studies of dermatomyositis. Dermatologica (1972) 0.82
Immunopathology of cicatricial pemphigoid: studies of complement deposition. J Invest Dermatol (1977) 0.82
Complement fixation by Brazilian Pemphigus foliaceus autoantibodies. Clin Exp Immunol (1988) 0.81
An appraisal of routine direct immunofluorescence in vulvar disorders. Acta Derm Venereol (1981) 0.81
Neonatal lupus erythematosus. A report of three cases associated with anti-Ro/SSA antibodies. Arch Dermatol (1985) 0.81
Expression of pemphigus vulgaris antigen in cultured human keratinocytes: effect of inhibitors, tunicamycin, and lectins. J Invest Dermatol (1988) 0.80
Clq binding activity in lupus erythematosus: correlation with the "lupus band test". J Invest Dermatol (1978) 0.80
Bullous pemphigoid: a cause of peripheral blood eosinophilia. J Am Acad Dermatol (1983) 0.80
Concurrent linear scleroderma and systemic lupus erythematosus: a report of two cases. J Invest Dermatol (1979) 0.79
Immunofluorescence of epithelial skin tumors. II. Basement membrane. Cancer (1970) 0.79
Immunopathology of oral mucosal inflammatory diseases. Clin Exp Dermatol (1977) 0.79
Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen. J Lab Clin Med (1988) 0.79
Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes. J Clin Invest (1988) 0.79
Bullous pemphigoid associated with systemic lupus erythematosus. Arch Dermatol (1969) 0.78
Circulating immune complexes in systemic scleroderma and generalized morphea. Dermatologica (1980) 0.78
A study of lupus erythematosus with particular reference to generalized discoid lupus. Br J Dermatol (1978) 0.77
The complement system in bullous pemphigoid: VII. Fixation of the regulatory protein beta 1H globulin by pemphigoid antibody. J Invest Dermatol (1980) 0.77
Systemic lupus erythematosus diagnosed during interferon alfa therapy. South Med J (1996) 0.77
Immunohistochemical studies of the human cutaneous basement membrane-anchoring fibril complex. J Invest Dermatol (1977) 0.77
C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies. Arch Dermatol (1982) 0.77
Anti-Ro/SSA antibodies. Association with a particulate (large speckledlike thread) immunofluorescent nuclear staining pattern. Arch Dermatol (1985) 0.77
The immunopathology of pemphigus and bullous pemphigoid. 1968. J Invest Dermatol (1989) 0.76
Immunopathology in pemphigus. Clin Dermatol (1987) 0.76
Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy. Arch Dermatol (1992) 0.75
The surgical applications and implications of cultured human epidermis: a comprehensive review. Surgery (1992) 0.75
Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor. Clin Exp Immunol (1981) 0.75
Chronic cutaneous lupus erythematosus. Med Clin North Am (1989) 0.75
Bullous dermatoses. J Am Acad Dermatol (1984) 0.75
Lupus erythematosus. Dermatol Clin (1986) 0.75
[Lymphocyte population (T and B lymphocytes) in the peripheral blood of healthy controls and in various dermatoses (preliminary report)]. Actas Dermosifiliogr (1975) 0.75
Bullous pemphigoid: elution of in vivo-fixed antibody. J Invest Dermatol (1973) 0.75
Desquamative gingivitis. Clinical, histopathologic, and immunopathologic investigations. Oral Surg Oral Med Oral Pathol (1976) 0.75
Chronic nonhereditary blistering disease in children. Arch Dermatol (1974) 0.75
[Chemotactic activity in the fluid of bullous pemphigoid blisters]. Med Cutan Ibero Lat Am (1975) 0.75
The pre-Sezary erythroderma syndrome. Mayo Clin Proc (1974) 0.75
Cryofibrinogenemia in a patient with B-cell lymphoma. Clin Lymphoma (2000) 0.75
The anti-Ro antibody system. Int J Dermatol (1986) 0.75
Hypocomplementemic ear effusion in relapsing polychondritis. Mayo Clin Proc (1976) 0.75
Treatment of Sezary syndrome. Mayo Clin Proc (1974) 0.75
The immunopathology of bullous pemphigoid. Clin Dermatol (1987) 0.75
Complement fixation by IgA in skin in dermatitis herpetiformis. Lancet (1973) 0.75
Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus. Arch Dermatol (1974) 0.75
The application of glucose oxidase-labeled antibodies for the detection of proteins on nitrocellulose. J Immunol Methods (1986) 0.75
[Treatment of pemphigus]. Med Cutan Ibero Lat Am (1974) 0.75